Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Industry Today.
Press releases published on December 15, 2025
December 15, 2025
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
Indeterminate
GlobeNewswire
December 15, 2025
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
Indeterminate
GlobeNewswire
December 15, 2025
CEMATRIX Announces $6.9 Million in New Contract Awards
Indeterminate
GlobeNewswire
December 15, 2025
GeeFi (GEE) Announces Crypto Card, Aiming to Bridge Digital Assets With Real-World Spending
Indeterminate
GlobeNewswire
December 15, 2025
XOMA Royalty Enters into Agreement to Acquire Generation Bio
Indeterminate
GlobeNewswire
December 15, 2025
Perimeter Solutions Prices Offering of $550 Million of Senior Secured Notes Due 2034
Indeterminate
GlobeNewswire
December 15, 2025
Cellectis Announces Arbitral Decision in Dispute with Servier
Indeterminate
GlobeNewswire
December 15, 2025
Cellectis annonce la décision du tribunal arbitral dans le litige l’opposant à Servier
Indeterminate
GlobeNewswire
December 15, 2025
Update on Predictive Acquisition
Indeterminate
GlobeNewswire
December 15, 2025
BioSyent Announces Renewal of Normal Course Issuer Bid
Indeterminate
GlobeNewswire
December 15, 2025
Paramount Gold Announces the Voting Results of Its 2025 Annual General Meeting
Indeterminate
GlobeNewswire
December 15, 2025
Terra Rossa Gold Ltd. Announces Launch of Company Website
Indeterminate
GlobeNewswire
December 15, 2025
Brookfield Renewable Announces Renewal of Normal Course Issuer Bids
Indeterminate
GlobeNewswire
December 15, 2025
WSP to acquire TRC, supercharging its leading position in the Power & Energy sector
Indeterminate
GlobeNewswire
December 15, 2025
WSP fera l’acquisition de TRC, propulsant sa position de chef de file dans le secteur Énergie
Indeterminate
GlobeNewswire
December 15, 2025
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
Indeterminate
GlobeNewswire